Hierarchical clustering of the correlation matrix suggests that the expression of three PP2A inhibitors, ARPP19, PME1 and SET, form a cluster with similar expression patterns across AML patient samples (Figure 1i). Here, ARPP19 is linked to acute myeloid leukemia.